ClassID:

92812

C07C233/87 - CPC Classification

Classification description:

Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings

Recent Application in this class:
#1
20260055051
2026-02-26

Compound with anti-tumor activity, preparation method therefor, and use thereof

#2
20250313535
2025-10-09

ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF

#3
20230174497
2023-06-08

RHEIN AMIDE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF, AND INHIBITOR OF HEPATOCELLULAR CARCINOMA (HCC) WITH SPECIFIC RECQL4 EXPRESSION

#4
20230150925
2023-05-18

USP9X inhibitors

#5
20220127220
2022-04-28

Compounds and methods for treating influenza

#6
20210053967
2021-02-25

Compounds for inhibition of α4 β7 integrin

#7
20200216490
2020-07-09

PPAR agonists and methods of use thereof

#8
20200190019
2020-06-18

PPAR agonists

#9
20200188407
2020-06-18

Compounds and methods for inducing chondrogenesis

#10
20200172473
2020-06-04

DUAL MODULATORS OF FARNESOID X RECEPTOR AND SOLUBLE EPOXIDE HYDROLASE

#11
20190328706
2019-10-31

COMPOSITIONS COMPRISING AN INTEGRIN INHIBITOR AND AGENTS WHICH INTERACT WITH A CHEMOKINE AND METHODS OF USE THEREOF

#12
20180305403
2018-10-25

PPAR agonists and methods of use thereof

#13
20180244606
2018-08-30

Farnesoid X receptor agonists and uses thereof

#14
20180170857
2018-06-21

PPAR agonists

#15
20180161313
2018-06-14

Inhibitors of Mc1-1 as drugs to overcome resistance to BRAF inhibitors and MEK inhibitors

#16
20170320828
2017-11-09

Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof

#17
20170273933
2017-09-28

Anti-tumor compound and the medical use thereof

#18
20160304441
2016-10-20

Benzamide derivatives useful in the treatment of muscular disorders and pain and for controlling spasticity and tremors

#19
20160297784
2016-10-13

Taxanes compounds, preparation method therefor, and uses thereof

#20
20160107996
2016-04-21

Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof

#21
20160045514
2016-02-18

Compounds and methods for inducing chondrogenesis

#22
20160023991
2016-01-28

PPAR agonists

#23
20160002149
2016-01-07

Carboxamide compounds

#24
20150174089
2015-06-25

Substituted aminobutyric derivatives as neprilysin inhibitors

#25
20150087758
2015-03-26

Thermoplastic polymer composition

#26
20140296559
2014-10-02

Synthesis of R-biphenylalaninol

#27
20140271955
2014-09-18

Compounds and methods for inducing chondrogenesis

#28
20140179947
2014-06-26

Process for manufacture and resolution of 2-acylamino-3-diphenylpropanoic acid

#29
20140171310
2014-06-19

Pesticidal compositions and processes related thereto

#30
20140142320
2014-05-22

Process for the manufacture of N-acylbiphenyl alanine

#31
20130289109
2013-10-31

INHIBITORS OF ALPHA4 MEDIATED CELL ADHESION

#32
20130225588
2013-08-29

Substituted naphthylacetic acids

#33
20120308588
2012-12-06

Neprilysin inhibitors

#34
20120252830
2012-10-04

Substituted aminobutyric derivatives as neprilysin inhibitors

#35
20120203023
2012-08-09

Process For Preparing A Phenylalanine Derivative

#36
20120202854
2012-08-09

4-substituted phenoxyphenylacetic acid derivatives

#37
20120190820
2012-07-26

Facile amide formation via S-nitroso thioacid intermediates

#38
20120088782
2012-04-12

LPA RECEPTOR ANTAGONIST

#39
20120016151
2012-01-19

Process for manufacture and resolution of 2-acylamino-3-diphenylpropanoic acid

#40
20120015443
2012-01-19

Chiral selectors and stationary phases for separating enantiomer mixtures

#41
20120004198
2012-01-05

Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators

#42
20110313154
2011-12-22

Method for preparing phenylalanine derivatives having quinazoline-dione skeleton and intermediates for use in the preparation of the derivatives

#43
20110306542
2011-12-15

GLP-1 receptor stabilizers and modulators

#44
20110144153
2011-06-16

Amide compound

#45
20110077299
2011-03-31

Inhibitors of αmediated cell adhesion

#46
20110028463
2011-02-03

AMIDE COMPOUNDS

#47
20100331410
2010-12-30

Biaryl Amides

#48
20100305145
2010-12-02

Substituted aminobutyric derivatives as neprilysin inhibitors

#49
20100266714
2010-10-21

P2Xreceptor antagonists for treatment of pain

#50
20100249157
2010-09-30

LPA receptor antagonist

#51
20100204505
2010-08-12

Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof

#52
20100173955
2010-07-08

4-substituted phenoxyphenylacetic acid derivatives

#53
20100113820
2010-05-06

Inhibitors of αmediated cell adhesion

#54
20090325962
2009-12-31

TYROSINE DERIVATIVE

#55
20090318714
2009-12-24

ORGANIC COMPOUNDS

#56
20090318688
2009-12-24

Method for preparing phenylalanine derivatives having quinazoline-dione skeleton and intermediates for use in the preparation of derivatives

#57
20090240052
2009-09-24

Anthranilic acid derivative or salt thereof

#58
20090238882
2009-09-24

Carbon-substituted diketopiperazine delivery systems

#59
20090229352
2009-09-17

Chiral selectors and stationary phases for separating enantiomer mixtures

#60
20090215628
2009-08-27

Benzoyl-Substituted Alanines

#61
20090203663
2009-08-13

CHEMICAL COMPOUNDS

#62
20090187017
2009-07-23

PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED BETA-AMINO ACID DERIVATIVES

#63
20090111879
2009-04-30

Inhibitors of αmediated cell adhesion

#64
20090062340
2009-03-05

Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof

#65
20090029903
2009-01-29

1,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors

#66
20090012129
2009-01-08

Biaromatic compounds that modulate PPAR-receptors

#67
20080312296
2008-12-18

Bifunctional synthetic molecules

#68
20080293764
2008-11-27

LPA receptor antagonist

#69
20080200542
2008-08-21

Benzoyl-substituted serineamides

#70
20080167310
2008-07-10

MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR)

#71
20080132574
2008-06-05

BLT2-mediated disease, BLT2 binding agent and the compound

#72
20080027134
2008-01-31

Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use

#73
20080008764
2008-01-10

CARBON-SUBSTITUTED DIKETOPIPERAZINE DELIVERY SYSTEMS

#74
20070208185
2007-09-06

Intermediates for the hemisynthesis of taxanes and preparation processes therefor

#75
20070185204
2007-08-09

Crystalline forms of 3-biphenyl-4-yl-(2S)-[(4'-trifluoromethyl-biphenyl-4-carbonyl)-amino]-propionic acid, and methods of use

#76
20070142230
2007-06-21

Benzoyl-substituted phenylalanineamides

#77
20070032646
2007-02-08

Novel taxanes and methods related to use and preparation thereof

#78
20070032474
2007-02-08

Use of a compound of formula 1 for making a pharmaceutical composition

#79
20060276518
2006-12-07

Aryl and heteroaryl compounds and methods to modulate coagulation

#80
20060155143
2006-07-13

Methods for producing acylphenylalanine

#81
20060148830
2006-07-06

LPA receptor antagonist

#82
20060134130
2006-06-22

Oral drug delivery compositions and methods

#83
20060106011
2006-05-18

2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation

#84
20060074110
2006-04-06

Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4

#85
20060014956
2006-01-19

Asymmetric Michael and Aldol additions using bifunctional cinchona-alkaloid-based catalysts

#86
20060009476
2006-01-12

Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof

#87
20050282900
2005-12-22

Inhibitors of alpha4 mediated cell adhesion

#88
20050272815
2005-12-08

Compounds and compositions for delivering active agents

#89
20050256116
2005-11-17

Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof

#90
20050255138
2005-11-17

Active agent transport systems

#91
20050222089
2005-10-06

Intermediates for the hemisynthesis of taxanes and preparation processes therefor

#92
20050215598
2005-09-29

Phenylalanine derivatives

#93
20050186176
2005-08-25

Compounds and compositions for delivering active agents

#94
20050165107
2005-07-28

Process for preparing a phenylalanine derivative and intermediates thereof

#95
20050142156
2005-06-30

Carbon-substituted diketopiperazine delivery systems

#96
20050101671
2005-05-12

Compounds and compositions for delivering active agents

#97
20050075378
2005-04-07

Modulators of peroxisome proliferator activated receptors (PPAR)

#98
20050065188
2005-03-24

Aryl or heteroaryl amide compounds

#99
20050059713
2005-03-17

Aryl and heteroaryl compounds, compositions, and methods of use

#100
20050059705
2005-03-17

Aryl and heteroaryl compounds, compositions, and methods of use

#101
20050049310
2005-03-03

Aryl and heteroaryl compounds, compositions and methods of use

#102
20050020584
2005-01-27

Benzamide derivatives as antagonists of orexin receptors

#103
20050014833
2005-01-20

Cyclic compound and PPAR agonist

#104
20050004398
2005-01-06

Process for the separation of R(-)-and S(+)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2- methoxybenzenesulfonamide